UNCY Stock Analysis: Buy, Sell, or Hold?
UNCY - Unicycive Therapeutics, Inc. Common Stock
$8.31
0.05 (0.61%)
▲
5d:
+4.53%
30d:
+18.38%
90d:
+33.6%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Smart Money Accumulation
UNCY is down 7.1% this week, but smart money is accumulating calls. Top strike: $7.5 2026-07-17 with 791 OI. Call ratio: 83% View Scanner →
Strength: 6.8/10
Get Alerted When UNCY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called UNCY this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: UNCY trades at premium valuation expecting 26.2% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: UNCY trades at premium valuation expecting 26.2% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.58
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$3.47
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UNCY is currently trading at $8.31, which is considered extended relative to its 30-day fair value range of $6.82 to $8.03. From a valuation perspective, the stock is trading at a premium (Forward PE: 2.1) compared to its historical average (1.0). At these levels, the market is pricing in 26.2% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, UNCY is in a strong uptrend. Immediate support is located at $7.70, while resistance sits at $8.74.
Market Sentiment: UNCY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.99 (+396.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, UNCY is in a strong uptrend. Immediate support is located at $7.70, while resistance sits at $8.74.
Market Sentiment: UNCY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.99 (+396.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.82 -
$8.03
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 396.3% below Wall St target ($40.99)
- BEARISH: Market expects 26.2% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$6.82 -
$8.03
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.70
Resistance Level
$8.74
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.07
Wall Street Target
$40.99
(+396.3%)
Valuation Premium vs History
+26.2% premium
PE vs Historical
2.1 vs 1.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+26.2%
(market-implied from PE analysis)
1-Year Target
$10.42
(+26%)
2-Year Target
$13.16
(+59%)
3-Year Target
$16.60
(+101%)
3-Yr Target (if PE normalizes)
(PE: 2→1)
PE COMPRESSION
$8.01
(-3%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: May 18, 2026 10:33 AM ET
Data refreshes hourly during market hours. Next update: 11:33 AM
Data refreshes hourly during market hours. Next update: 11:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UNCY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 51 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 55 HOLD |
